OBJECTIVES: HIV disease is associated with increased arterial stiffness, which may be related to inflammation provoked by HIV-related immune perturbation. We assessed the association of T cell markers of immune activation and immunosenescence with carotid artery stiffness among HIV-infected women. METHODS: Among 114 HIV-infected and 43 HIV-uninfected women, we measured CD4+ and CD8+ T cell populations expressing activation (CD38+HLA-DR+) and senescence (CD28-CD57+) markers. We then related these measures of immune status with parameters of carotid artery stiffness, including decreased distensibility, and increased Young's elastic modulus, as assessed by B-mode ultrasound. RESULTS: HIV infection was associated with increased CD4+ T cell activation, CD8+ T cell activation and CD8+ T cell senescence. Among HIV-infected women, adjusted for age, HIV medications, and vascular risk factors, higher CD4+CD38+HLA-DR+ T cell frequency was associated with decreased carotid artery distensibility (β=-2.00, 95% confidence interval [CI]=-3.86, -0.14, P=0.04) and increased Young's modulus (β=1.00, 95% CI=0.03, 1.97, P=0.04). These associations were affected little by further adjustment for CD4+ T cell count and viral load. Among HIV-infected women, higher frequencies of immunosenescent T cells, including CD4+CD28-CD57+ and CD8+CD28-CD57+ T cells, were also associated with decreased arterial distensibility. Among HIV-uninfected women, frequencies of activated or senescent T cells were not significantly associated with measures of carotid stiffness. DISCUSSION: T cell activation and senescence are associated with arterial stiffness, suggesting that pro-inflammatory populations of T cells may produce functional or structural vascular changes in HIV-infected women.
OBJECTIVES:HIV disease is associated with increased arterial stiffness, which may be related to inflammation provoked by HIV-related immune perturbation. We assessed the association of T cell markers of immune activation and immunosenescence with carotid artery stiffness among HIV-infectedwomen. METHODS: Among 114 HIV-infected and 43 HIV-uninfectedwomen, we measured CD4+ and CD8+ T cell populations expressing activation (CD38+HLA-DR+) and senescence (CD28-CD57+) markers. We then related these measures of immune status with parameters of carotid artery stiffness, including decreased distensibility, and increased Young's elastic modulus, as assessed by B-mode ultrasound. RESULTS:HIV infection was associated with increased CD4+ T cell activation, CD8+ T cell activation and CD8+ T cell senescence. Among HIV-infectedwomen, adjusted for age, HIV medications, and vascular risk factors, higher CD4+CD38+HLA-DR+ T cell frequency was associated with decreased carotid artery distensibility (β=-2.00, 95% confidence interval [CI]=-3.86, -0.14, P=0.04) and increased Young's modulus (β=1.00, 95% CI=0.03, 1.97, P=0.04). These associations were affected little by further adjustment for CD4+ T cell count and viral load. Among HIV-infectedwomen, higher frequencies of immunosenescent T cells, including CD4+CD28-CD57+ and CD8+CD28-CD57+ T cells, were also associated with decreased arterial distensibility. Among HIV-uninfectedwomen, frequencies of activated or senescent T cells were not significantly associated with measures of carotid stiffness. DISCUSSION: T cell activation and senescence are associated with arterial stiffness, suggesting that pro-inflammatory populations of T cells may produce functional or structural vascular changes in HIV-infectedwomen.
Authors: Eric C Seaberg; Lorie Benning; A Richey Sharrett; Jason M Lazar; Howard N Hodis; Wendy J Mack; Mark J Siedner; John P Phair; Lawrence A Kingsley; Robert C Kaplan Journal: Stroke Date: 2010-08-26 Impact factor: 7.914
Authors: G Regina; G Impedovo; D Angiletta; F Martiradonna; A Lillo; F Perilli; V Marotta; A Marzullo; G Epifani; J R Fiore; P Maggi Journal: Eur J Vasc Endovasc Surg Date: 2005-02 Impact factor: 7.069
Authors: Jacqueline Neuhaus; David R Jacobs; Jason V Baker; Alexandra Calmy; Daniel Duprez; Alberto La Rosa; Lewis H Kuller; Sarah L Pett; Matti Ristola; Michael J Ross; Michael G Shlipak; Russell Tracy; James D Neaton Journal: J Infect Dis Date: 2010-06-15 Impact factor: 5.226
Authors: Jennifer E Ho; Steven G Deeks; Frederick M Hecht; Yu Xie; Amanda Schnell; Jeffrey N Martin; Peter Ganz; Priscilla Y Hsue Journal: AIDS Date: 2010-07-31 Impact factor: 4.177
Authors: Frank J Palella; Stephen J Gange; Lorie Benning; Lisa Jacobson; Robert C Kaplan; Alan L Landay; Russell P Tracy; Richard Elion Journal: AIDS Date: 2010-07-17 Impact factor: 4.177
Authors: Peter W Hunt; Jason Brenchley; Elizabeth Sinclair; Joseph M McCune; Michelle Roland; Kimberly Page-Shafer; Priscilla Hsue; Brinda Emu; Melissa Krone; Harry Lampiris; Daniel Douek; Jeffrey N Martin; Steven G Deeks Journal: J Infect Dis Date: 2008-01-01 Impact factor: 5.226
Authors: Giuseppe Schillaci; Giuseppe V L De Socio; Giacomo Pucci; Massimo R Mannarino; Johny Helou; Matteo Pirro; Elmo Mannarino Journal: Hypertension Date: 2008-06-16 Impact factor: 10.190
Authors: Jason D Barbour; Emilie C Jalbert; Dominic C Chow; Louie Mar A Gangcuangco; Philip J Norris; Sheila M Keating; John Heitman; Lorna Nagamine; Todd Seto; Lishomwa C Ndhlovu; Beau K Nakamoto; Howard N Hodis; Nisha I Parikh; Cecilia M Shikuma Journal: Atherosclerosis Date: 2013-10-31 Impact factor: 5.162
Authors: Roksana Karim; Wendy J Mack; Naoko Kono; Phyllis C Tien; Kathryn Anastos; Jason Lazar; Mary Young; Seema Desai; Elizabeth T Golub; Robert C Kaplan; Howard N Hodis; Andrea Kovacs Journal: J Acquir Immune Defic Syndr Date: 2014-11-01 Impact factor: 3.731
Authors: Heather N Grome; Louise Barnett; Cindy C Hagar; David G Harrison; Spyros A Kalams; John R Koethe Journal: AIDS Res Hum Retroviruses Date: 2016-09-14 Impact factor: 2.205
Authors: Jessica L Castilho; Bryan E Shepherd; John Koethe; Megan Turner; Sally Bebawy; James Logan; William B Rogers; Stephen Raffanti; Timothy R Sterling Journal: AIDS Date: 2016-03-27 Impact factor: 4.177
Authors: C T Longenecker; N T Funderburg; Y Jiang; S Debanne; N Storer; D E Labbato; M M Lederman; G A McComsey Journal: HIV Med Date: 2013-01-18 Impact factor: 3.180